Baglin TP - Search Results

1

Predicting response to recombinant factor VIIa in non-haemophiliac patients with severe haemorrhage.

Bowles KM, Callaghan CJ, Taylor AL, Harris RJ, Pettigrew GJ, Baglin TP, Park GR. Bowles KM, et al. Among authors: baglin tp. Br J Anaesth. 2006 Oct;97(4):476-81. doi: 10.1093/bja/ael205. Epub 2006 Aug 16. Br J Anaesth. 2006. PMID: 16914465 Free article.

2

Discrepancy between impedance and immunofluorescence platelet counting has implications for clinical decision making in patients with idiopathic thrombocytopenia purpura.

Bowles KM, Bloxham DM, Perry DJ, Baglin TP. Bowles KM, et al. Among authors: baglin tp. Br J Haematol. 2006 Aug;134(3):320-2. doi: 10.1111/j.1365-2141.2006.06165.x. Br J Haematol. 2006. PMID: 16848774 Free article.

3

Platelet mass has prognostic value in patients with myelodysplastic syndromes.

Bowles KM, Warner BA, Baglin TP. Bowles KM, et al. Among authors: baglin tp. Br J Haematol. 2006 Oct;135(2):198-200. doi: 10.1111/j.1365-2141.2006.06246.x. Epub 2006 Aug 25. Br J Haematol. 2006. PMID: 16939490 Free article.

4

Platelet size has diagnostic predictive value in patients with thrombocytopenia.

Bowles KM, Cooke LJ, Richards EM, Baglin TP. Bowles KM, et al. Among authors: baglin tp. Clin Lab Haematol. 2005 Dec;27(6):370-3. doi: 10.1111/j.1365-2257.2005.00726.x. Clin Lab Haematol. 2005. PMID: 16307537

5

The clinical utility of Multiplate analyser measurement in platelet function testing following stroke and transient ischaemic attack.

Mannu GS, Macartney A, Lambert JR, Bettencourt-Silva JH, Lawn M, Lyall H, Metcalf AK, Potter JF, Wood J, Clark A, Baglin T, Myint PK, Bowles KM. Mannu GS, et al. Eur J Haematol. 2015 Feb;94(2):138-44. doi: 10.1111/ejh.12406. Epub 2014 Jul 24. Eur J Haematol. 2015. PMID: 24981148

6

Beriplex P/N reverses severe warfarin-induced overanticoagulation immediately and completely in patients presenting with major bleeding.

Evans G, Luddington R, Baglin T. Evans G, et al. Br J Haematol. 2001 Dec;115(4):998-1001. doi: 10.1046/j.1365-2141.2001.03214.x. Br J Haematol. 2001. PMID: 11843839 Free article. Clinical Trial.

7

Guidelines on the use and monitoring of heparin.

Baglin T, Barrowcliffe TW, Cohen A, Greaves M; British Committee for Standards in Haematology. Baglin T, et al. Br J Haematol. 2006 Apr;133(1):19-34. doi: 10.1111/j.1365-2141.2005.05953.x. Br J Haematol. 2006. PMID: 16512825 Free article. No abstract available.

8

Severe factor X deficiency due to a homozygous mutation (Cys364Arg) that disrupts a disulphide bond in the catalytic domain.

Todd T, Perry DJ, Hayman E, Lawrence K, Gattens M, Baglin T. Todd T, et al. Haemophilia. 2006 Nov;12(6):621-4. doi: 10.1111/j.1365-2516.2006.01315.x. Haemophilia. 2006. PMID: 17083512

9

Defining the population in need of thromboprophylaxis - making hospitals safer.

Baglin T. Baglin T. Br J Haematol. 2010 Jun;149(6):805-12. doi: 10.1111/j.1365-2141.2010.08158.x. Epub 2010 Apr 26. Br J Haematol. 2010. PMID: 20433681 Free article. Review.

10

Analysis of risk factors for over-anticoagulation in patients receiving long-term warfarin.

Panneerselvam S, Baglin C, Lefort W, Baglin T. Panneerselvam S, et al. Br J Haematol. 1998 Nov;103(2):422-4. doi: 10.1046/j.1365-2141.1998.00988.x. Br J Haematol. 1998. PMID: 9827914 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

236 results

Search Page

Filters